ArticleCell cycle (Georgetown, Tex.)2012

Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.

Lenka Oplustilova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.